3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
53
Thoracic
3
Genitourinary
3
Lymphoid
1
Head & Neck
1
Conditions
Lymphoma
2570
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2085
Lymphoma, Non-Hodgkin
2057
Leukemia, Lymphocytic, Chronic, B-Cell
1771
Lymphoma, Follicular
1651
Lymphoma, Large B-Cell, Diffuse
1597
Leukemia
1171
Hodgkin Disease
1128
Lymphoma, Mantle-Cell
1110
Burkitt Lymphoma
887
Leukemia, Myeloid, Acute
885
Lymphoma, B-Cell, Marginal Zone
788
Recurrence
778
Multiple Myeloma
744
Lymphoma, B-Cell
703
Myelodysplastic Syndromes
615
Neoplasms
493
Lymphoma, T-Cell, Cutaneous
479
Waldenstrom Macroglobulinemia
470
Lymphoma, Large-Cell, Immunoblastic
456
Mycosis Fungoides
383
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
382
Lymphoma, Large-Cell, Anaplastic
362
Sezary Syndrome
321
Lymphoma, T-Cell, Peripheral
321
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
307
Hematologic Neoplasms
299
Myeloproliferative Disorders
288
Neoplasms, Plasma Cell
270
Blast Crisis
261
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Liver Cirrhosis
×
Lymphoid
×
Clear all
NCT06812780
2025-09-24
CAMPOLINA
AstraZeneca
Phase 1
Completed
35 enrolled